These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1084929)

  • 21. [Lymphocyte imbalance in autoimmunity].
    Manni JA; Guilleron C; Araujo HA
    Medicina (B Aires); 1989; 49(2):105-8. PubMed ID: 2640477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased number of peripheral blood CD4 + CD29+ lymphocytes and increased in vitro spontaneous production of anti-DNA antibodies in patients with active systemic lupus erythematosus.
    Gorla R; Airò P; Franceschini F; Stefani E; Braga S; Tincani A; Cattaneo R
    J Rheumatol; 1990 Aug; 17(8):1048-53. PubMed ID: 1698987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-dimensional flow cytometric analysis of peripheral blood T lymphocytes from patients with systemic lupus erythematosus: preferential expression of HLA-DR antigen on the surface of Leu 2a+ cells.
    Tsuchiya N; Mitamura T; Goto M; Moroi Y; Kinoshita M; Yokohari R; Miyamoto T
    J Rheumatol; 1988 Jun; 15(6):946-51. PubMed ID: 3262161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus.
    Winfield JB; Shaw M; Minota S
    J Immunol; 1986 May; 136(9):3246-53. PubMed ID: 3007614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
    Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
    J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N; Tsuchida T; Tamaki K
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B lymphocytopenia in infectious mononucleosis.
    Sumaya CV; Keightley RG
    Clin Exp Immunol; 1981 Feb; 43(2):298-301. PubMed ID: 6268336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T; Jakab L; Fehér J
    Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus.
    Minota S; Winfield JB
    J Immunol; 1987 Dec; 139(11):3644-51. PubMed ID: 3500225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
    Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
    Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus.
    Winfield JB; Winchester RJ; Kunkel HG
    Arthritis Rheum; 1975; 18(6):587-94. PubMed ID: 1081876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of alloantigens on human Fc receptor-bearing lymphocytes: the presence of B cell alloantigens on sIg-positive but not sIg-negative lymphocytes.
    Nelson DL; Strober W; Abelson LD; Bundy BM; Mann DL
    J Immunol; 1977 Mar; 118(3):943-6. PubMed ID: 300392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte-reactive antibodies in SLE.
    Searles RP; Williams RC
    Clin Rheum Dis; 1982 Apr; 8(1):77-90. PubMed ID: 6214367
    [No Abstract]   [Full Text] [Related]  

  • 36. T and B lymphocyte function in patients with lupus nephritis: correlation with renal pathology.
    Balow JE; Tsokos GC
    Clin Nephrol; 1984 Feb; 21(2):93-7. PubMed ID: 6233052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
    Nowak JS; Lanzrein C
    Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pan T, T4 and T8-positive lymphocytes in the peripheral blood of patients with systemic lupus erythematosus].
    Grunow R; Volk HD; von Baehr R
    Z Gesamte Inn Med; 1987 Mar; 42(5):130-4. PubMed ID: 2954308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte antigens in systemic lupus erythematosus: studies with heterologous antisera.
    Williams RC; Hughes GR; Snaith ML; Parry HF; Diao E; Greaves MF
    J Clin Invest; 1980 Feb; 65(2):379-89. PubMed ID: 6153183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.